Have a personal or library account? Click to login
Telemedicine During COVID 19 - A Useful Tool in COPD Patient Management Cover

Telemedicine During COVID 19 - A Useful Tool in COPD Patient Management

Open Access
|Oct 2020

References

  1. 1. J. Matusitz, G.-M. Breen, Telemedicine: its effects on health communication, Health Commun. 21 (2007) 73–83, http://dx.doi.org/10.1080/10410230701283439.10.1080/10410230701283439
  2. 2. R.L. Bashshur, G.W. Shannon, B.R. Smith, D.C. Alverson, N. Antoniotti,W.G. Barsan, N. Bashshur, E.M. Brown, M.J. Coye, C.R. Doarn, S. Ferguson, J. Grigsby, E.A. Krupinski, J.C. Kvedar, J. Linkous, R.C. Merrell, T. Nesbitt, R. Poropatich, K.S. Rheuban, J.H. Sanders, A.R. Watson, R.S. Weinstein, P. Yellowlees, The empirical foundations of telemedicine interventions for chronic disease management, Telemed. J. E-Health Off. J. Am. Telemed. Assoc. 20 (2014),769–800, http://dx.doi.org/10.1089/tmj.2014.998110.1089/tmj.2014.9981
  3. 3. Ambrosino N, Vagheggini G, Mazzoleni S,Vitacca M. -Telemedicine in chronic obstructive pulmonary disease. Breathe 2016; 12: 350–35610.1183/20734735.014616
  4. 4. Mihăl an Fl, Coşei V., Borcea C., Ancuţa CTelemedicine in chronic obstructive pulmonary disease: a possible transition to the patient independence-Pneumologia (in press) -2020-0006 69 2020 1-510.2478/pneum-2020-0006
  5. 5. Ancochea J, García-Río F, Vázquez-Espinosa E, HernandoSanz A, López-Yepes L, Galera-Martínez R, et al. Efficacy and costs of telehealth for the management of COPD: the PROMETE II trial. European Respiratory Journal. 2018;51(5): pii:1800354.10.1183/13993003.00354-2018
  6. 6. Segrelles Calvo G, Gómez-Suárez C, Soriano JB, Zamora E, Gónzalez-Gamarra A, González-Béjar M, et al. A home telehealth program for patients with severe COPD: the PROMETE study. Respiratory Medicine. 2014;108(3): 453–46210.1016/j.rmed.2013.12.003
  7. 7. Lenferink A, Brusse-Keizer M, van der Valk PD, et al. Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2017; 8: CD011682.10.1002/14651858.CD011682.pub2
  8. 8. Criner GJ, Bourbeau J, Diekemper RL, et al. Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. Chest 2015; 147: 894–942.10.1378/chest.14-1676
  9. 9. Bourbeau J, Farias R. Making sense of telemedicine in the management of COPD. Eur. Respir J 2018; 51: 1800851 [https://doi.org/10.1183/13993003.00851-2018].10.1183/13993003.00851-2018
  10. 10. Zhao Q, Meng M, Kumar R, et al. The impact of COPD and smoking history on the severity of Covid-19: A systemic review and meta-analysis [published online ahead of print, 2020 Apr 15]. J Med Virol. 2020;10.1002/jmv.25889. doi:10.1002/jmv.2588910.1002/jmv.25889
  11. 11. Nussbaumer-Streit_B, Mayr_V, Dobrescu_AI, Chapman_A, Persad_E, Klerings_I, Wagner_G, Siebert_U, Christof_C, Zachariah_C, Gartlehner_G.-Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review. Cochrane Database of Systematic Reviews 2020, Issue 4. Art. No.: CD013574. DOI: 10.1002/14651858.CD013574.10.1002/14651858.CD013574
DOI: https://doi.org/10.2478/inmed-2020-0123 | Journal eISSN: 1220-5818 | Journal ISSN: 1220-5818
Language: English
Page range: 35 - 47
Published on: Oct 14, 2020
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 Florin Mihălţan, Corina Oprea, Valentin Coşei, Bogdan Mut, Ancuţa Constantin, published by Romanian Society of Internal Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.